ALISO VIEJO, Calif. and REHOVOT, Israel, Dec. 14 Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd. (TASE: BIOV) today jointly ...
NASHVILLE, Tenn. and GLEN ROCK, N.J., Dec. 14 HealthLeaders-InterStudy and Fingertip Formulary find that over the next five years, a greater percentage of health plans will transition orally delivered oncology drugs from a copayment ...
The College of American Pathologists Offers Free Web site -- www.MyBiopsy.org -- to Help Patients Understand this Deadly Disease WHAT: In 2010, more than 159,000 people will die from lung cancer. Bryant Gumbel's announcement that he ...
THE WOODLANDS, Texas, Dec. 14 Seven leading cancer physicians and investigators affiliated with US Oncology Research participated in studies that were presented orally at the 2009 San Antonio Breast Cancer Symposium, held Dec. 9-13 at the Henry B. ...
MORRISTOWN, N.J., Dec. 14 Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy ...
HELSINKI, Dec. 14 Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR) at the only private radiotherapy clinic in the ...
Westchester Medical Center Physician and Fertility Preservation Expert leads study examining the association of breast cancer genes, breast cancer and infertility VALHALLA, N.Y. , Dec. 11 /PRNewswire-USNewswire/ -- In a study published ...
COLUMBIA, S.C., Dec. 11 African-American women in South Carolina are 37 percent more likely to have cervical cancer than white women and have a death rate that is about 61 percent higher, according to a study by researchers at the University of ...
LONDON and PHILADELPHIA, Dec. 11 In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® ...
SAN ANTONIO, Dec. 11 Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for ...
Discover how the U.S. plans to invest $7.2 billion in cancer research for 2025 and learn about top states, charities, and key factors influencing cancer research.
Discover how a groundbreaking blood test using advanced DNA sequencing techniques is set to revolutionize early cancer detection.
Breakthrough in cancer detection: Biolaser can detect pancreatic and lung cancer cells early without destroying them.
Artificial Intelligence enhances the accuracy of ovarian cancer detection, offering more reliable and timely diagnoses for better patient outcomes.
New research shows that cellular architecture can predict how kidney cancer patients will respond to treatment, offering potential for more personalized therapies.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers